Chung Kevin purchased $7K of ICU

Chung Kevin (Chief Medical Officer) purchased 7,800 shares of SeaStar Medical Holding Corp (ICU) at $0.84 on 2026-11-16.

Original reporting
SEC EDGAR · Chung Kevin
Published Nov 17, 2026, 11:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 11:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ICU
Neutral
medium confidence
Mentioned
$ICU
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ICUNeutralLow
01

Why it matters

This provides incremental sentiment information (insider buying) but no operational or financial update that would typically reset valuation expectations.

02

Market read

Traders may note the insider purchase, but the disclosure alone is unlikely to be a standalone catalyst.

03

What to watch

The filing does not state the insider’s rationale, and the absence of a 10b5-1 plan does not by itself confirm conviction or timing advantage.

Relevance 4/10Novelty 6/10Timing: filed 2026-11-17, transaction dated 2026-11-16

Background

The article is an SEC Form 4 insider transaction disclosure for SeaStar Medical Holding Corp.

Company-level read

Ticker impact

$ICUNeutralMedium confidence
Context

SeaStar Medical Holding CMO Kevin Chung bought 7,800 shares at $0.8448 on 2026-11-16, per a fresh SEC Form 4 filing.

Expected impact

Likely limited near-term impact, with any effect confined to sentiment around insider activity.

Evidence & confidence

The disclosure is a primary Form 4, but the transaction size is small and there is no accompanying guidance, deal, or operational catalyst in the text.

Market effects

Minimal, as this is company-specific insider activity with no sector-wide signal in the provided text.

None indicated.

None indicated.

Counterpoint

Insider buys can reflect diversification or routine liquidity needs rather than a strong forward-looking signal, especially without a 10b5-1 plan context.

Key entities

  • SeaStar Medical Holding Corp

    US-listed company (ICU) whose CMO filed an insider purchase on Form 4.

  • Kevin Chung

    Chief Medical Officer who purchased shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ICUHigh

SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates

SeaStar Medical Holding Corp (ICU) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates Continued adoption of the QUELIMMUNE ® therapy yielded 247% increase in net revenue compared to the third quarter of 2025 Achieved nearly 75% enrollment in the NEUTRALIZE-AKI p